ADIPOQ and liver disorder: However, the association between hyperleptinemia and insulin resistance, and lack of protective effect of adiponectin, despite its increasing levels with progression of liver disease, provide some valuable insight into the metabolic aspects of cirrhosis in this specific clinical population.